Novorex
PrivateLast Round
Series B
Apr 9, 2026
Est. Valuation
$41.08M
Total Funding Raised
$33.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Novorex is a biotechnology company that develops small-molecule drugs for cancer and central nervous system diseases using an AI-driven, fragment-based drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Warehouse Automation, Pharma Supply Chain, Supply Chain Tracking
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novorex Comparables
Compare Novorex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ScriptPro | 79% | |
| ARxIUM | 78% | |
| JVM Co., Ltd. | 78% |
Novorex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 9, 2026 | ||||
| Series A Extension | Nov 21, 2023 | ||||
| Series A | Jul 1, 2021 | ||||
| Pre Seed | Feb 1, 2020 |
Novorex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series A Extension |
| KOTEC | Series A Extension |
| BNH INVESTMENT | Series A Extension |
| Hyundai Venture Investment Corporation | Series B |
| UTC Investment | Series B, Series A Extension |
| KB Investment | Series B, Series A Extension |
| Samsung Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$14.1M round with participation from KB Securities and Hyundai Venture Investment Corporation.
- Nov 21, 2023
Raised $9M from UTC Investment, BNH Investment, and others.
Novorex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novorex's valuation, stock price, and market status.
Is Novorex a public or private company?
Novorex is a private company.
What is the current stock price of Novorex?
Novorex is a private company with no public stock price. No recent secondary market data is available.
How much is Novorex worth (valuation)?
Novorex's valuation is estimated at $41.1M based on funding round data.
Can I buy Novorex stock?
Novorex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Novorex's last funding round?
Novorex's most recent funding round was Series B on April 9, 2026.
Who are the main investors in Novorex?
Key investors in Novorex include Hana Ventures, KOTEC, BNH INVESTMENT, Hyundai Venture Investment Corporation, UTC Investment.
Will Novorex IPO soon?
No public IPO plans have been announced for Novorex.
How can I track Novorex secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novorex's secondary market activity and sign up for updates.